GU Research Network

GU Research Network (GURN) is a specialized clinical research organization and network of community-based urology practices dedicated to advancing treatments for genitourinary (GU) oncology. Founded in 2010 by Dr. Luke Nordquist, the organization has established itself as a global leader in the field of theranostics and radiopharmaceutical clinical trials. GURN provides pharmaceutical and biotech sponsors with a streamlined infrastructure for Phase 1 through Phase 4 trials, offering rapid site activation and exceptionally high patient accrual rates. The network is particularly recognized for its pivotal role in the development of landmark therapies, having served as a lead site for trials such as VISION and ALSYMPCA. Today, GURN operates as a core component of the broader XCancer network, continuing to provide patients with access to cutting-edge investigational treatments close to home.